We could not find any results for:
Make sure your spelling is correct or try broadening your search.
L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - HBP Canada NewsWire TORONTO, le 1er avril 2024 TORONTO, le 1er avril 2024 /CNW/...
Canadian Investment Regulatory Organization Trade Resumption - HBP Canada NewsWire TORONTO, April 1, 2024 TORONTO, April 1, 2024 /CNW/ - Trading resumes in: Company: Helix BioPharma Corp. TSX...
Suspension de la négociation par l'Organisme canadien de réglementation des investissements - HBP Canada NewsWire TORONTO, le 28 mars 2024 TORONTO, le 28 mars 2024 /CNW/...
Canadian Investment Regulatory Organization Trading Halt - HBP Canada NewsWire TORONTO, March 28, 2024 TORONTO, March 28, 2024 /CNW/ - The following issues have been halted by CIRO: Company:...
RICHMOND HILL, Ontario, July 30, 2020 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: “HBP”), a an immuno-oncology company developing drug candidates for the prevention and treatment of cancer...
RICHMOND HILL, Ontario, July 13, 2020 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the...
RICHMOND HILL, Ontario, June 26, 2020 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP) (“Helix” or the “Company”), a clinical-stage biopharmaceutical company developing unique therapies in...
NEW YORK, June 22, 2020 (GLOBE NEWSWIRE) -- Proactive, the digital financial news organization, will be showcasing four rising stars of the life sciences industry with its first North American...
RICHMOND HILL, Ontario, June 22, 2020 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the...
RICHMOND HILL, Ontario, June 11, 2020 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.03 | -3 | 1 | 1 | 0.87 | 5943 | 0.9966145 | CS |
4 | 0.22 | 29.3333333333 | 0.75 | 1.06 | 0.71 | 8791 | 0.96030357 | CS |
12 | -0.09 | -8.49056603774 | 1.06 | 1.34 | 0.5 | 11818 | 0.83876781 | CS |
26 | -0.18 | -15.652173913 | 1.15 | 1.35 | 0.5 | 8795 | 0.96675606 | CS |
52 | -0.08 | -7.61904761905 | 1.05 | 1.35 | 0.5 | 9228 | 0.96770838 | CS |
156 | -0.78 | -44.5714285714 | 1.75 | 1.875 | 0.5 | 13574 | 1.10854897 | CS |
260 | -6.53 | -87.0666666667 | 7.5 | 10.05 | 0.5 | 17225 | 2.21853015 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions